Learn more

BIOBUD CO LTD

Overview
  • Total Patents
    50
About

BIOBUD CO LTD has a total of 50 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are JAPAN HEALTH SCIENCES FOUND, VIROVAHL SA and SINOBIOWAY BIOMEDICINE CO LTD.

Patent filings per year

Chart showing BIOBUD CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chung Kwang Hoe 26
#2 Hong Sung Yu 19
#3 Hwang Jae Hoon 14
#4 Chung Kwang-Hoe 12
#5 Sohn Young Doug 11
#6 Jung Gwang Hoe 9
#7 Kim Ok Hwan 8
#8 Choi Won Seok 7
#9 Koh You-Seok 7
#10 Kang Soo Jung 7

Latest patents

Publication Filing date Title
KR20130119085A Separating vials and their uses
KR20120103032A Separator and collection vial
KR20120017215A Blood coagulation measuring device and method of synthesizing the same
KR20110035725A Novel compound as photosensitizer used to photodynamic therapy
KR20090116669A Mutated Nucleotide Sequences of Batroxobin, Mutated α-Factor Secretion Signal Sequence and Processes for Preparing Batroxobin Using the Same
KR20100118244A Novel bis-(3-hydroxy-4-methyl-phenyl) derivatives and methods for preparing the same
KR20100000471A Methods for preparing nano-patterned epoxy templates
KR20090071852A MUTATED NUCLEOTIDE SEQUENCES OF BATROXOBIN, MUTATED alpha-FACTOR SECRETION SIGNAL SEQUENCE AND PROCESSES FOR PREPARING BATROXOBIN USING THE SAME
KR20080077889A Pharmaceutical compositions for treating or preventing cancer
KR20080077888A Inhibitors to proliferation of smooth muscle cells
KR20080112761A Compositions for inhibiting the proliferation of smooth muscle cells comprising damaged vessel targeting nanoparticles
KR20080105372A Novel multidrug resistance inhibitory compound and pharmaceutical composition comprising the same
WO2008102932A1 Compositions for treating hyperproliferative vascular disorders and cancers
KR20080026991A Recombinant gene for mass production of modified tissue type plasminogen activator and protein refolding method thereof
EP1917532A1 Monoclonal antibody against d-dimer and diagnosis agent for detecting d-dimer, crosslinked fibrin and its derivatives containing d-dimer by using the antibody
KR20060017348A Cell-transducing botoxin fusion protein
KR20050121082A Green tea extract having a improved taste and manufacturing method thereof
KR20050107152A Nanoparticle comprising vascular smooth muscle cell inhibitor and the preparation method
WO2004081023A1 Solubilization method of water-insoluble curcumin
KR20050090260A A novel compound and use as inhibitor of vascular smooth muscle cell thereof